Screening for infectious maternal morbidity – knowledge, attitudes and perceptions among healthcare providers and managers in Malawi: a qualitative study

listen audio

Study Justification:
– Maternal morbidity and mortality related to infection is a global public health concern.
– Detection and assessment of infectious maternal morbidity is challenging in low- and middle-income countries due to limited access to diagnostics.
– Front-line healthcare providers play a crucial role in identifying and managing women with infection.
– This study aims to investigate the knowledge, attitudes, and perceptions of healthcare providers regarding the use of screening tools for infectious maternal morbidity during and after pregnancy.
Study Highlights:
– Key informant interviews and focus group discussions were conducted with healthcare providers and managers in a large tertiary public hospital in Blantyre, Malawi.
– Most healthcare providers recognize the importance of early detection of infection and would like to improve identification if resources were available.
– Currently, an early warning score is only used in the high dependency unit, and routine screening is not implemented in the antenatal or postnatal departments.
– Barriers to implementing routine screening include lack of trained staff, time constraints, lack of thermometers, and difficulties with interpreting early warning scores.
– Local adaptation of an early warning screening tool is seen as an enabler for implementing routine screening.
– Local ownership and clinical leadership are considered essential for successful and sustainable implementation of clinical change.
Recommendations:
– Establish standardized screening for infectious maternal morbidity as part of routine antenatal and postnatal care.
– Provide free and easily accessible rapid diagnostic testing for infections.
– Offer training in the interpretation of test results.
– Ensure affordable targeted treatment for identified infections.
– Carefully consider and validate the implementation of early warning scores and processes developed in high-income countries for low-resource settings.
Key Role Players:
– Trained healthcare providers (doctors, nurses, midwives) to conduct screening and interpret results.
– Healthcare managers (ward matron, head of department, head of facility) to support and oversee the implementation of routine screening.
– Clinical leaders to provide guidance and ensure successful implementation.
Cost Items for Planning Recommendations:
– Training programs for healthcare providers on screening and interpretation of test results.
– Procurement of rapid diagnostic testing equipment and supplies.
– Development and adaptation of a locally appropriate early warning screening tool.
– Implementation support and supervision from healthcare managers and clinical leaders.
– Budget allocation for targeted treatment of identified infections.
Please note that the cost items provided are general categories and not actual cost estimates. The specific costs will depend on the context and resources available in Malawi.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is based on qualitative research conducted with healthcare providers and managers in a large tertiary public hospital in Malawi. The study used key informant interviews and focus group discussions to explore knowledge, attitudes, and perceptions of screening for infectious maternal morbidity. The findings highlight the importance of early detection of infection and the barriers to implementing routine screening. However, the evidence is limited to a single hospital and may not be generalizable to other settings. To improve the strength of the evidence, future studies could include a larger sample size and involve multiple healthcare facilities in different regions of Malawi. Additionally, quantitative data could be collected to complement the qualitative findings and provide a more comprehensive understanding of the topic.

Background: Maternal morbidity and mortality related to infection is an international public health concern, but detection and assessment is often difficult as part of routine maternity care in many low- and middle-income countries due to lack of easily accessible diagnostics. Front-line healthcare providers are key for the early identification and management of the unwell woman who may have infection. We sought to investigate the knowledge, attitudes, and perceptions of the use of screening tools to detect infectious maternal morbidity during and after pregnancy as part of routine antenatal and postnatal care. Enabling factors, barriers, and potential management options for the use of early warning scores were explored. Methods: Key informant interviews (n = 10) and two focus group discussions (n = 14) were conducted with healthcare providers and managers (total = 24) working in one large tertiary public hospital in Blantyre, Malawi. Transcribed interviews were coded by topic and then grouped into categories. Thematic framework analysis was undertaken to identify emerging themes. Results: Most healthcare providers are aware of the importance of the early detection of infection and would seek to better identify women with infection if resources were available to do so. In current practice, an early warning score was used in the high dependency unit only. Routine screening was not in place in the antenatal or postnatal departments. Barriers to implementing routine screening included lack of trained staff and time, lack of thermometers, and difficulties with the interpretation of the early warning scores. A locally adapted early warning screening tool was considered an enabler to implementing routine screening for infectious morbidity. Local ownership and clinical leadership were considered essential for successful and sustainable implementation for clinical change. Conclusions: Although healthcare providers considered infection during and after pregnancy and childbirth a danger sign and significant morbidity, standardised screening for infectious maternal morbidity was not part of routine antenatal or postnatal care. The establishment of such a service requires the availability of free and easy to access rapid diagnostic testing, training in interpretation of results, as well as affordable targeted treatment. The implementation of early warning scores and processes developed in high-income countries need careful consideration and validation when applied to women accessing care in low resource settings.

Key informant interviews and focus group discussions were conducted with healthcare providers working in the obstetric department the Queen Elizabeth Hospital, in Blantyre, Malawi, in June 2019 (prior to Covid-19 pandemic caused by SARS-Co-V). This hospital is the largest teaching hospital in the south of Malawi providing routine and specialised antenatal, intrapartum, and postnatal care, in addition to receiving high risk referrals from surrounding healthcare facilities. There are on average 1000 deliveries per month, with a Caesarean rate of 30%. All interviews were held a quiet office in the healthcare facility away from the clinic rooms to ensure privacy. Healthcare providers (doctors, nurses, midwives) were included if they provided routine maternity care (including antenatal and postnatal care) at the chosen study site. Healthcare managers (Ward matron, Head of Department, Head of facility) were included to enable the triangulation of the data and broadened the scope of the topic. Snowballing and opportunistic sampling techniques were employed to identify the participants. Participants were chosen purposively, based on their ability to speak English, and were recruited sequentially until data saturation was met. A topic guide was developed and piloted at the study site in Malawi. The topic guide was a flexible tool that enabled the interviewer to capture the healthcare providers’ responses as well as acting as a cue to probe further to understand the participants’ perceptions and beliefs (Supplementary File 1). In addition to sociodemographic questions, the topic guide included five main subject areas: (1) overall understanding of screening for infectious morbidity (2) knowledge and perception of early warning scores; (3) experience and views on use of early warning scores; (4) approaches to management of women with infectious morbidity; and (5) suggestions on how to identify or screen women with possible infectious maternal morbidity. Key informant interviews and focus group discussions were conducted face-to-face in English, lasted on average 30–45 min, were recorded on a digital recording device, and transcribed on completion. Anonymity and confidentiality with regards to data reporting were emphasised to reassure participants’ confidence in providing honest answers. All participants approached agreed to participate in the study and completed the interviews. The interviews and focus group discussions were transcribed verbatim by the first author (ES). The first author (ES) and a second reviewer (HWU) independently coded all transcripts. The identified codes were grouped into categories and reviewed by three researchers (ES, HU, MMC) to ensure consistency. This enabled the first extraction of data [36]. Key themes were then discussed and checked by all researchers together to reach consensus. We used the Standards for Reporting Qualitative Research guidelines in reporting the analysis [37]. Ethical approval was granted by the Liverpool School of Tropical Medicine, UK (LSTM14.025) and by the University of Malawi College of Medicine Research and Ethics Committee (COMREC 2724). This research was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants of the study.

The recommendation to improve access to maternal health based on the study titled “Screening for infectious maternal morbidity – knowledge, attitudes and perceptions among healthcare providers and managers in Malawi: a qualitative study” is to implement routine screening for infectious maternal morbidity during and after pregnancy as part of routine antenatal and postnatal care. This recommendation is supported by the findings that most healthcare providers are aware of the importance of early detection of infection and would seek to better identify women with infection if resources were available. Currently, routine screening is not in place in the antenatal or postnatal departments due to barriers such as lack of trained staff and time, lack of thermometers, and difficulties with the interpretation of early warning scores.

To address these barriers and enable routine screening, the study suggests the following:

1. Develop a locally adapted early warning screening tool: This tool can be specifically designed to detect infectious maternal morbidity and can be used during antenatal and postnatal care. It should be easy to use and interpret, taking into consideration the resources available in low-resource settings.

2. Provide training in interpretation of results: Healthcare providers should receive training on how to interpret the results of the screening tool. This will ensure that they can accurately identify women with possible infectious maternal morbidity and provide appropriate care.

3. Ensure availability of free and easy-to-access rapid diagnostic testing: To support the implementation of routine screening, there should be access to rapid diagnostic tests that are affordable and readily available. This will facilitate the early detection of infections and enable timely treatment.

4. Foster local ownership and clinical leadership: Successful and sustainable implementation of routine screening requires local ownership and clinical leadership. Healthcare providers and managers should be actively involved in the development and implementation of the screening program to ensure its effectiveness and sustainability.

By implementing routine screening for infectious maternal morbidity, healthcare providers can identify and manage infections early, leading to improved maternal health outcomes. This recommendation can contribute to improving access to maternal health by integrating screening into routine antenatal and postnatal care.
AI Innovations Description
The recommendation to improve access to maternal health based on the study titled “Screening for infectious maternal morbidity – knowledge, attitudes and perceptions among healthcare providers and managers in Malawi: a qualitative study” is to implement routine screening for infectious maternal morbidity during and after pregnancy as part of routine antenatal and postnatal care. This recommendation is supported by the findings that most healthcare providers are aware of the importance of early detection of infection and would seek to better identify women with infection if resources were available. Currently, routine screening is not in place in the antenatal or postnatal departments due to barriers such as lack of trained staff and time, lack of thermometers, and difficulties with the interpretation of early warning scores.

To address these barriers and enable routine screening, the study suggests the following:

1. Develop a locally adapted early warning screening tool: This tool can be specifically designed to detect infectious maternal morbidity and can be used during antenatal and postnatal care. It should be easy to use and interpret, taking into consideration the resources available in low-resource settings.

2. Provide training in interpretation of results: Healthcare providers should receive training on how to interpret the results of the screening tool. This will ensure that they can accurately identify women with possible infectious maternal morbidity and provide appropriate care.

3. Ensure availability of free and easy-to-access rapid diagnostic testing: To support the implementation of routine screening, there should be access to rapid diagnostic tests that are affordable and readily available. This will facilitate the early detection of infections and enable timely treatment.

4. Foster local ownership and clinical leadership: Successful and sustainable implementation of routine screening requires local ownership and clinical leadership. Healthcare providers and managers should be actively involved in the development and implementation of the screening program to ensure its effectiveness and sustainability.

By implementing routine screening for infectious maternal morbidity, healthcare providers can identify and manage infections early, leading to improved maternal health outcomes. This recommendation can contribute to improving access to maternal health by integrating screening into routine antenatal and postnatal care.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations for improving access to maternal health:

1. Implement routine screening for infectious maternal morbidity: Establish standardized screening protocols for infectious morbidity during and after pregnancy as part of routine antenatal and postnatal care. This can help identify and manage infections early, reducing maternal morbidity and mortality.

2. Provide training on interpretation of screening results: Offer training programs to healthcare providers on how to interpret screening results for infectious maternal morbidity. This will ensure accurate diagnosis and appropriate treatment.

3. Ensure availability of diagnostic testing: Improve access to free and easily accessible rapid diagnostic testing for infectious maternal morbidity. This will enable healthcare providers to promptly diagnose infections and initiate targeted treatment.

4. Develop a locally adapted early warning screening tool: Create a screening tool specifically tailored to the local context in Malawi. This tool should be easy to use, culturally appropriate, and effective in identifying women with possible infectious maternal morbidity.

5. Strengthen clinical leadership and local ownership: Foster a sense of ownership and leadership among healthcare providers and managers in implementing routine screening for infectious morbidity. This will help ensure successful and sustainable implementation of the recommended changes.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific population that will be affected by the recommendations, such as pregnant women and healthcare providers in Malawi.

2. Collect baseline data: Gather data on the current state of access to maternal health services, including the prevalence of infectious maternal morbidity, existing screening practices, and barriers to access.

3. Develop a simulation model: Create a mathematical or computational model that represents the healthcare system and the impact of the recommendations. This model should consider factors such as population size, healthcare infrastructure, resource availability, and the effectiveness of the proposed interventions.

4. Input data and parameters: Input the collected baseline data and relevant parameters into the simulation model. This may include data on the population size, healthcare provider capacity, diagnostic testing availability, and the expected impact of the recommendations on improving access to maternal health.

5. Run simulations: Run multiple simulations using different scenarios and assumptions to assess the potential impact of the recommendations. This could involve varying factors such as the coverage of screening, the effectiveness of training programs, and the availability of diagnostic testing.

6. Analyze results: Analyze the simulation results to determine the potential impact of the recommendations on improving access to maternal health. This may include evaluating changes in the prevalence of infectious maternal morbidity, the number of women identified and treated for infections, and the overall improvement in maternal health outcomes.

7. Validate the model: Validate the simulation model by comparing the results with real-world data and expert opinions. This will help ensure the accuracy and reliability of the simulation findings.

8. Communicate findings: Present the simulation findings in a clear and concise manner, highlighting the potential benefits of implementing the recommendations to improve access to maternal health. This can inform decision-making and policy development at the local, national, or international level.

It is important to note that the specific methodology for simulating the impact of recommendations may vary depending on the available data, resources, and expertise. Collaboration with experts in the field of maternal health and simulation modeling can help refine the methodology and ensure its validity.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email